| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007
Exogenous sphingosine-1-phosphate (SPP) inhibits chemotactic motility of several transformed cell lines. We have found that SPP at high micromolar concentrations decreased chemotaxis of estrogen-independent (MDA-MB-231 and BT 549) and estrogen-dependent (MCF-7 and ZR-75-1) human breast cancer cells. Because SPP has been implicated as a lipid-signaling molecule with novel dual intra- and intercellular actions, it was of interest to determine whether the effect of SPP on chemotactic motility of human breast cancer cells is mediated intracellularly or through the recently identified endothelial differentiation gene (EDG) family of G protein-coupled SPP receptors. There was no detectable specific binding of [32P]SPP to MDA-MB-231 or MCF-7 cells; however, reverse transcription-PCR analysis revealed that both MDA-MB-231 and MCF-7 cells expressed moderate levels of EDG-3, neither expressed EDG-1, and EDG-5 mRNA was expressed in MCF-7 but not in MDA-MB-231 cells. In contrast to SPP, sphinganine-1-phosphate, which binds to and signals through SPP receptors EDG-1, EDG-3, and EDG-5, had no effect on chemotactic motility of MDA-MB-231 or MCF-7 cells. To further discriminate between intracellular and receptor-mediated actions of SPP, we used caged SPP, a photolyzable derivative of SPP that elevates intracellular levels of SPP after illumination. Caged SPP inhibited chemotactic motility of MDA-MB-231 cells only upon UV irradiation. In addition, in MCF-7 cells, overexpression of sphingosine kinase, the enzyme that produces SPP, inhibited chemotactic motility compared with vector-transfected cells and markedly increased cellular SPP levels in the absence of detectable secretion. Our results suggest that the inhibitory effect of SPP on chemotactic motility of human breast cancer cells is likely mediated through intracellular actions of SPP rather than through cell surface receptors.
This article has been cited by other articles:
![]() |
O. Sukocheva, L. Wang, E. Verrier, M. A. Vadas, and P. Xia Restoring Endocrine Response in Breast Cancer Cells by Inhibition of the Sphingosine Kinase-1 Signaling Pathway Endocrinology, October 1, 2009; 150(10): 4484 - 4492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kusner, C. R. Thompson, N. A. Melrose, S. M. Pitson, L. M. Obeid, and S. S. Iyer The Localization and Activity of Sphingosine Kinase 1 Are Coordinately Regulated with Actin Cytoskeletal Dynamics in Macrophages J. Biol. Chem., August 10, 2007; 282(32): 23147 - 23162. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sukocheva, C. Wadham, A. Holmes, N. Albanese, E. Verrier, F. Feng, A. Bernal, C. K. Derian, A. Ullrich, M. A. Vadas, et al. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 J. Cell Biol., April 24, 2006; 173(2): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Hait, S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel Role of Sphingosine Kinase 2 in Cell Migration toward Epidermal Growth Factor J. Biol. Chem., August 19, 2005; 280(33): 29462 - 29469. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Jolly, M. Bektas, K. R. Watterson, H. Sankala, S. G. Payne, S. Milstien, and S. Spiegel Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors Blood, June 15, 2005; 105(12): 4736 - 4742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bektas, S. G. Payne, H. Liu, S. Goparaju, S. Milstien, and S. Spiegel A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells J. Cell Biol., June 6, 2005; 169(5): 801 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Le Stunff, A. Mikami, P. Giussani, J. P Hobson, P. S. Jolly, S. Milstien, and S. Spiegel Role of Sphingosine-1-phosphate Phosphatase 1 in Epidermal Growth Factor-induced Chemotaxis J. Biol. Chem., August 13, 2004; 279(33): 34290 - 34297. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Olivera, H. M. Rosenfeldt, M. Bektas, F. Wang, I. Ishii, J. Chun, S. Milstien, and S. Spiegel Sphingosine Kinase Type 1 Induces G12/13-mediated Stress Fiber Formation, yet Promotes Growth and Survival Independent of G Protein-coupled Receptors J. Biol. Chem., November 21, 2003; 278(47): 46452 - 46460. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Sukocheva, L. Wang, N. Albanese, S. M. Pitson, M. A. Vadas, and P. Xia Sphingosine Kinase Transmits Estrogen Signaling in Human Breast Cancer Cells Mol. Endocrinol., October 1, 2003; 17(10): 2002 - 2012. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Clair, J. Aoki, E. Koh, R. W. Bandle, S. W. Nam, M. M. Ptaszynska, G. B. Mills, E. Schiffmann, L. A. Liotta, and M. L. Stracke Autotaxin Hydrolyzes Sphingosylphosphorylcholine to Produce the Regulator of Migration, Sphingosine-1-Phosphate Cancer Res., September 1, 2003; 63(17): 5446 - 5453. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arikawa, N. Takuwa, H. Yamaguchi, N. Sugimoto, J. Kitayama, H. Nagawa, K. Takehara, and Y. Takuwa Ligand-dependent Inhibition of B16 Melanoma Cell Migration and Invasion via Endogenous S1P2 G Protein-coupled Receptor: REQUIREMENT OF INHIBITION OF CELLULAR RAC ACTIVITY J. Biol. Chem., August 29, 2003; 278(35): 32841 - 32851. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, C. Foote, S. Alexander, and H. Alexander Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum Development, September 15, 2001; 128(18): 3473 - 3483. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, Y.-j. Xiao, L. M. Baudhuin, and B. M. Schwartz The Role and Clinical Applications of Bioactive Lysolipids in Ovarian Cancer Reproductive Sciences, January 1, 2001; 8(1): 1 - 13. [Abstract] [PDF] |
||||
![]() |
H. Okamoto, N. Takuwa, T. Yokomizo, N. Sugimoto, S. Sakurada, H. Shigematsu, and Y. Takuwa Inhibitory Regulation of Rac Activation, Membrane Ruffling, and Cell Migration by the G Protein-Coupled Sphingosine-1-Phosphate Receptor EDG5 but Not EDG1 or EDG3 Mol. Cell. Biol., December 15, 2000; 20(24): 9247 - 9261. [Abstract] [Full Text] |
||||
![]() |
S. Kim, H. Fyrst, and J. Saba Accumulation of Phosphorylated Sphingoid Long Chain Bases Results in Cell Growth Inhibition in Saccharomyces cerevisiae Genetics, December 1, 2000; 156(4): 1519 - 1529. [Abstract] [Full Text] |
||||
![]() |
J. H. Paik, S.-s. Chae, M.-J. Lee, S. Thangada, and T. Hla Sphingosine 1-Phosphate-induced Endothelial Cell Migration Requires the Expression of EDG-1 and EDG-3 Receptors and Rho-dependent Activation of alpha vbeta 3- and beta 1-containing Integrins J. Biol. Chem., April 6, 2001; 276(15): 11830 - 11837. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |